BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Varespladib methyl: Phase III ongoing

Anthera said that a DSMB recommended for the fifth time the continuation of the double-blind, placebo-controlled, international Phase III VISTA-16 trial based on a review of safety data from available patients. The study is evaluating once-daily 500 mg oral varespladib for...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >